192 related articles for article (PubMed ID: 382956)
1. [Lipoproteins, glucose tolerance and insulin secretion].
Debry G; Mejean L; Drouin P; Villaume C; Pointel JP; Vernhes G
Ann Nutr Aliment; 1979; 33(1):113-34. PubMed ID: 382956
[No Abstract] [Full Text] [Related]
2. Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, 3, IV, and V hyperlipoproteinemia.
Glueck CJ; Levy RI; Fredrickson DS
Diabetes; 1969 Nov; 18(11):739-47. PubMed ID: 5348517
[No Abstract] [Full Text] [Related]
3. [Thyroid gland dysfunction and metabolic abnormalities, with special reference to abnormal lipid and glucose metabolism].
Mashita K; Tarui S
Nihon Rinsho; 1980; 38(3):1656-65. PubMed ID: 6993732
[No Abstract] [Full Text] [Related]
4. Plasma triglycerides in human diabetes.
Nikkilä EA
Proc R Soc Med; 1974 Jun; 67(7):662-5. PubMed ID: 4212245
[No Abstract] [Full Text] [Related]
5. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
[No Abstract] [Full Text] [Related]
6. [Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
Schwandt P; Weisweiler P; Neureuther G; Wilkening J
MMW Munch Med Wochenschr; 1976 Mar; 118(12):351-4. PubMed ID: 177863
[TBL] [Abstract][Full Text] [Related]
7. Hypertriglyceridemia, diabetes mellitus, and coronary vessel disease.
Levy RI; Glueck CJ
Arch Intern Med; 1969 Mar; 123(3):220-8. PubMed ID: 4886256
[No Abstract] [Full Text] [Related]
8. [Hyperlipoproteinemia -- cause or sequelae of maturity-onset diabetes].
Bruns W; Rjasanowski I
Z Gesamte Inn Med; 1975 May; 30(10):57-9. PubMed ID: 1199246
[TBL] [Abstract][Full Text] [Related]
9. Insulin secretion in hyperlipoproteinemias.
Tiengo A; Muggeo M; Fedele D; Marchiori E; Crepaldi G
Acta Diabetol Lat; 1974; 11(2):148-64. PubMed ID: 4372840
[No Abstract] [Full Text] [Related]
10. Experimental production of syndrome of obesity, hyperinsulinemia and hyperlipidemia in monkeys.
Hamilton CL; Kuo PT; Feng LY
Proc Soc Exp Biol Med; 1972 Jul; 140(3):1005-8. PubMed ID: 5039361
[No Abstract] [Full Text] [Related]
11. The relationship between insulin secretion and triglyceride concentration in endogenous lipemia.
Eaton BP; Nye WH
J Lab Clin Med; 1973 May; 81(5):682-95. PubMed ID: 4349136
[No Abstract] [Full Text] [Related]
12. Plasma lipoproteins, glucose tolerance and insulin response in primary gout.
Wiedemann E; Rose HG; Schwartz E
Am J Med; 1972 Sep; 53(3):299-307. PubMed ID: 5054722
[No Abstract] [Full Text] [Related]
13. Carbohydrate metabolism in various types of hyperlipoproteinaemia.
Romics L; Stützel M; Balázsi I; Varsányi-Nagy M
Acta Med Acad Sci Hung; 1976; 33(3):225-32. PubMed ID: 1031550
[TBL] [Abstract][Full Text] [Related]
14. Type V hyperlipoproteinaemia. Metabolic changes in hyperlipaemic and previously hyperlipaemic ("susceptible") male patients.
Jacobsen BB
Atherosclerosis; 1973; 17(3):471-81. PubMed ID: 4577010
[No Abstract] [Full Text] [Related]
15. [The effect of therapy on serum lipoproteins, insulin secretion and glucose tolerance in newly discovered maturity onset diabetes].
Pissarek D; Adolph W; Schmechel H; Senf L; Lundershausen R; Panzram G
Z Gesamte Inn Med; 1977 Jan; 32(11):suppl 176 contd. PubMed ID: 930176
[No Abstract] [Full Text] [Related]
16. [Study of serum lipoproteins in diabetes mellitus. Clinicometabolic significance].
Strat C; Andriescu E; Lungu I; Ilarion FL; Terek C
Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):565-72. PubMed ID: 4375841
[No Abstract] [Full Text] [Related]
17. Metformin administration in hyperlipidemic states.
Gustafson A; Björntorp P; Fahlén M
Acta Med Scand; 1971 Dec; 190(6):491-4. PubMed ID: 5149092
[No Abstract] [Full Text] [Related]
18. Hyperlipoproteinemias and diabetes mellitus.
Pozza G
Adv Exp Med Biol; 1973; 38():133-42. PubMed ID: 4588023
[No Abstract] [Full Text] [Related]
19. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
Chen YD; Swami S; Skowronski R; Coulston A; Reaven GM
J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086
[TBL] [Abstract][Full Text] [Related]
20. [Incidence of hyperlipoproteinemia and other risk factors in chronic and acute phases of patients with myocardial infarct].
Diehl HJ; Sorge F; Hoffmann H; Weidener J; Schloss W; Schwartzkopff W
Arzneimittelforschung; 1972 Oct; 22(10):1815-8. PubMed ID: 4678571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
